HeartSciences’ CEO Andrew Simpson discusses heart disease and our AI-ECG solutions using both MyoVista hardware and MyoVista Insights cloud-based solutions
See the video: https://youtu.be/OrR2RtK3qvA
Millions of ECGs are performed every week, however, for decades these tests have largely remained unchanged. Conventional ECGs are easy and quick to perform, but unfortunately do not detect most heart disease conditions.
Artificial Intelligence-Enhanced Electrocardiography (AI-ECG) is set to transform cardiovascular medicine. AI-ECG allows previously unseen disease to be identified and radically expands the clinical usefulness of an ECG.
